Nanotechnology Companies

Add company into catalog:


  Registration / Why register?

Homepage next Nanotechnology Companies next Transition Therapeutics Inc.

Transition Therapeutics Inc.

Transition Therapeutics Inc.

It is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets.

The Company's lead CNS drug candidate is ELND005 for the treatment of agitation or aggression associated with Alzheimer's disease and Down syndrome. Transition's lead metabolic drug candidate is TT401 for the treatment of type 2 diabetes and accompanying obesity. Their main aims are CNS (Central Nervous System) disorders and Metabolic diseases.

Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |

Transition Therapeutics Inc.

101 College Street, Suite 220
M5G 1L7 Toronto

Phone: 416-260-7770

Share with friends:  

Next companies in category